Publication policy, informed consent, and the randomized clinical trial.
Publication
, Journal Article
Califf, RM
Published in: Am Heart J
February 2002
Duke Scholars
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
February 2002
Volume
143
Issue
2
Start / End Page
187 / 188
Location
United States
Related Subject Headings
- Recombinant Proteins
- Randomized Controlled Trials as Topic
- Publications
- Peptide Fragments
- Informed Consent
- Humans
- Hirudins
- Hirudin Therapy
- Decision Making
- Coronary Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M. (2002). Publication policy, informed consent, and the randomized clinical trial. Am Heart J, 143(2), 187–188. https://doi.org/10.1067/mhj.2002.120406
Califf, Robert M. “Publication policy, informed consent, and the randomized clinical trial.” Am Heart J 143, no. 2 (February 2002): 187–88. https://doi.org/10.1067/mhj.2002.120406.
Califf RM. Publication policy, informed consent, and the randomized clinical trial. Am Heart J. 2002 Feb;143(2):187–8.
Califf, Robert M. “Publication policy, informed consent, and the randomized clinical trial.” Am Heart J, vol. 143, no. 2, Feb. 2002, pp. 187–88. Pubmed, doi:10.1067/mhj.2002.120406.
Califf RM. Publication policy, informed consent, and the randomized clinical trial. Am Heart J. 2002 Feb;143(2):187–188.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
February 2002
Volume
143
Issue
2
Start / End Page
187 / 188
Location
United States
Related Subject Headings
- Recombinant Proteins
- Randomized Controlled Trials as Topic
- Publications
- Peptide Fragments
- Informed Consent
- Humans
- Hirudins
- Hirudin Therapy
- Decision Making
- Coronary Disease